ADPD 2025 Presentation

2025 ADPD:

ALTITUDE-AD: Use of a pTau217 Assay as a Marker of Amyloid Burden for Screening Participants in an Ongoing Phase 2 Study of Sabirnetug in Early Alzheimer’s Disease​

File Type: pdf
File Size: 2 MB
Categories: 2025
Tags: ALTITUDE-AD, Presentation, pTau217, sabirnetug, TwentyTwentyFive